RxDoctor Payments Data

Gene Kielhorn, DO

Family Medicine · Brooklyn, MINPI 1174629091

Payments from drug & device makers

$386in general payments, 2019–2025

Across 25 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$153
  • E.r. Squibb & Sons, L.L.C.$52
  • Pfizer$49
  • Sanofi Pasteur Inc.$33
  • GSK$28
  • Novo Nordisk$19
  • plus $52 from 3 others

What the payments were for

  • Food & beverage$386100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$386 in reported general payments places this provider in the 55th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$24,839
Medicare patients
62
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$84,238
TrulicityDulaglutide40$72,093
EliquisApixaban46$50,359
JanuviaSitagliptin Phosphate32$42,893
XareltoRivaroxaban27$25,316
JardianceEmpagliflozin24$22,947
Rosuvastatin Calcium272$7,723
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,046
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,439
Humalog Kwikpen U-100Insulin Lispro11$2,107
Ezetimibe49$1,759
Levothyroxine Sodium122$1,578
Albuterol Sulfate HfaAlbuterol Sulfate13$1,526
Metoprolol Succinate71$1,523
Losartan Potassium77$1,523

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$19$84,23865 claims
PfizerEliquis$49$50,35946 claims
Boehringer IngelheimJardiance$18$22,94724 claims
GSKTrelegy Ellipta$28$7,04611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Brooklyn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →